Velocity Clinical Research is the world’s leading site organization, comprising 80 owned and integrated clinical research sites empowered by 225 investigators across the U.S. and Europe. Velocity partners with pharmaceutical and biotechnology companies to research new treatments, medical devices, and diagnostic tools that could improve human health and wellbeing. The company’s infrastructure helps Sponsors and CROs shorten the time needed from concept to commercialization to get products to patients in need. Velocity is committed to delivering high-quality data, exemplary patient care, and unprecedented efficiency for clinical trials at any scale. Learn more at VelocityClinical.com.